Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment With NLY01 in Early-stage Parkinson's Disease
Neuraly Clinical Study
Principal Investigator: Chad Christine, MD
Contact: Aaron Daley, MS
415-476-9276
